220 related articles for article (PubMed ID: 8605938)
21. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
22. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
23. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
24. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
Kaufman DS; Schoon RA; Leibson PJ
J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
[TBL] [Abstract][Full Text] [Related]
25. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
[TBL] [Abstract][Full Text] [Related]
26. Ly-49-independent inhibition of natural killer cell-mediated cytotoxicity by a soluble major histocompatibility complex class I molecule.
Roth C; Kourilsky P; Ojcius DM
Eur J Immunol; 1994 Sep; 24(9):2110-4. PubMed ID: 8088332
[TBL] [Abstract][Full Text] [Related]
27. Negative regulation of rat natural killer cell activity by major histocompatibility complex class I recognition.
Kraus E; Lambracht D; Wonigeit K; Hünig T
Eur J Immunol; 1996 Nov; 26(11):2582-6. PubMed ID: 8921942
[TBL] [Abstract][Full Text] [Related]
28. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.
Moretta A; Vitale M; Sivori S; Bottino C; Morelli L; Augugliaro R; Barbaresi M; Pende D; Ciccone E; Lopez-Botet M; Moretta L
J Exp Med; 1994 Aug; 180(2):545-55. PubMed ID: 8046333
[TBL] [Abstract][Full Text] [Related]
29. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.
Riteau B; Rouas-Freiss N; Menier C; Paul P; Dausset J; Carosella ED
J Immunol; 2001 Apr; 166(8):5018-26. PubMed ID: 11290782
[TBL] [Abstract][Full Text] [Related]
30. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
[TBL] [Abstract][Full Text] [Related]
31. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.
Sullivan LC; Clements CS; Rossjohn J; Brooks AG
Tissue Antigens; 2008 Nov; 72(5):415-24. PubMed ID: 18946929
[TBL] [Abstract][Full Text] [Related]
32. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction.
Spaggiari GM; Contini P; Dondero A; Carosio R; Puppo F; Indiveri F; Zocchi MR; Poggi A
Blood; 2002 Dec; 100(12):4098-107. PubMed ID: 12393468
[TBL] [Abstract][Full Text] [Related]
33. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones.
Vitale M; Castriconi R; Parolini S; Pende D; Hsu ML; Moretta L; Cosman D; Moretta A
Int Immunol; 1999 Jan; 11(1):29-35. PubMed ID: 10050671
[TBL] [Abstract][Full Text] [Related]
34. HLA class I specificity for natural killer cell receptor CD94/NKG2A: two for one in more ways than one.
Yokoyama WM
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4791-4. PubMed ID: 9560179
[No Abstract] [Full Text] [Related]
35. Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with beta 2-microglobulin.
Carbone E; Stuber G; Andrée S; Franksson L; Klein E; Beretta A; Siccardi AG; Kärre K
Eur J Immunol; 1993 Aug; 23(8):1752-6. PubMed ID: 7688306
[TBL] [Abstract][Full Text] [Related]
36. Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors.
Terrazzano G; Zanzi D; Palomba C; Carbone E; Grimaldi S; Pisanti S; Fontana S; Zappacosta S; Ruggiero G
J Leukoc Biol; 2002 Aug; 72(2):305-11. PubMed ID: 12149421
[TBL] [Abstract][Full Text] [Related]
37. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.
Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
J Exp Med; 1993 Oct; 178(4):1321-36. PubMed ID: 8376937
[TBL] [Abstract][Full Text] [Related]
38. HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells.
Martini F; Agrati C; D'Offizi G; Poccia F
Int J Immunopathol Pharmacol; 2005; 18(2):269-76. PubMed ID: 15888249
[TBL] [Abstract][Full Text] [Related]
39. HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors.
Posch PE; Borrego F; Brooks AG; Coligan JE
J Biomed Sci; 1998; 5(5):321-31. PubMed ID: 9758906
[No Abstract] [Full Text] [Related]
40. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones.
Luque I; Solana R; Galiani MD; González R; García F; López de Castro JA; Peña J
Eur J Immunol; 1996 Aug; 26(8):1974-7. PubMed ID: 8765048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
